Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vanderbilt University Spasticity Management Program Evaluation Plan
NCT00179114Phase 4Completed
- Sponsor
- Vanderbilt University
- Start
- Aug 2002
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind, single-arm trial of botulinum toxin type A and baclofen in spasticity, sponsored by Vanderbilt University. Primary endpoints: Total time spent by caregivers to complete a defined care area task at 1 year and Categorical rating of care area task videos at 1 year. Started Aug 2002; status: completed.
02
Drugs
botulinum toxin type Abaclofen
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT00179114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00179114.